{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:14:56Z","timestamp":1791126896060,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 NS39985"],"award-info":[{"award-number":["RO1 NS39985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 ES10806"],"award-info":[{"award-number":["RO1 ES10806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Protein deposition diseases involve the aggregation of normally soluble proteins, leading to both fibrillar and amorphous deposits. The aggregation of \u03b1\u2010synuclein is associated with Parkinson's disease, and the aggregation of the A\u03b2 peptide is associated with Alzheimer's disease. Here we show that L\u2010dopa, dopamine, and other catecholamines dissolve fibrils of \u03b1\u2010synuclein and A\u03b2 peptide generated in vitro. The catecholamines also inhibited the fibrillation of these proteins. In addition, intraneuronal \u03b1\u2010synuclein deposits formed in a mouse model were dissolved by incubation of tissue slices with L\u2010dopa. These catecholamines are susceptible to oxidative breakdown, and we show that oxidation products are more effective than the parent compounds in inhibition. The ability to dissolve fibrils provides a new approach for studying mechanisms and consequences (e.g., the relationship between fibril formation and neurodegeneration) of protein aggregation. It is also likely to help in the development of strategies for the prevention and treatment of protein deposition diseases.<\/jats:p>","DOI":"10.1096\/fj.03-0770fje","type":"journal-article","created":{"date-parts":[[2004,4,5]],"date-time":"2004-04-05T20:33:26Z","timestamp":1081197206000},"page":"962-964","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Dopamine and L\u2010dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease"],"prefix":"10.1096","volume":"18","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry University of California Santa Cruz California"},{"name":"The Parkinson's Institute 1170 Morse Avenue Sunnyvale California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry University of California Santa Cruz California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Manning-Bog","sequence":"additional","affiliation":[{"name":"The Parkinson's Institute 1170 Morse Avenue Sunnyvale California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato A.","family":"Di Monte","sequence":"additional","affiliation":[{"name":"The Parkinson's Institute 1170 Morse Avenue Sunnyvale California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Fink","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry University of California Santa Cruz California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02073-4"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199603000-00001"},{"key":"e_1_2_6_4_1","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba M.","year":"1998","journal-title":"Am. J. Pathol."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2001.047"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5300.630"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(01)00283-4"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)48018-0"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)48021-0"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033137"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-04-01484.1999"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/10715769609088005"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb09437.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2428"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.7.2959"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(00)00034-X"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.110138997"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)02380-2"},{"key":"e_1_2_6_19_1","first-page":"93","article-title":"Brefeldin A inhibits experimentally induced AA amyloidosis","volume":"23","author":"Stenstad T.","year":"1996","journal-title":"J. Rheumatol."},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/bj3400283","article-title":"Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans","volume":"340","author":"Howlett D. R.","year":"1999","journal-title":"Biochem. J."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206593200"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj3510273","article-title":"The molecular interaction of 4'-iodo-4'-deoxydoxorubicin with Leu-55Pro transthyretin \u2018amyloid-like\u2019 oligomer leading to disaggregation","volume":"351","author":"Sebastiao M. P.","year":"2000","journal-title":"Biochem. J."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1063522"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(01)00462-7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109541200"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100551200"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00367-3"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.203"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.498"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100560200"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00164a008"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi991447r"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010907200"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi020139h"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi9904149"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/418291a"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)01175-0"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(89)90046-8"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)13535-9"},{"key":"e_1_2_6_40_1","first-page":"503","article-title":"Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy","volume":"147","author":"Schmidt M. L.","year":"1995","journal-title":"Am. J. Pathol."},{"key":"e_1_2_6_41_1","first-page":"174","article-title":"Forensic neuropathological and immunohistochemical studies on Alzheimer- type dementia (AD\/SDAT)","volume":"44","author":"Tatsuno Y.","year":"1990","journal-title":"Nippon Hoigaku Zasshi"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/neur.1996.0025","article-title":"Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads","volume":"5","author":"Cullen K. M.","year":"1996","journal-title":"Neurodegeneration"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-18-07226.2001"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi001315u"},{"key":"e_1_2_6_45_1","first-page":"183","article-title":"Neuroprotection by dopamine agonists","volume":"43","author":"Lange K. W.","year":"1994","journal-title":"J. Neural Transm. Suppl."},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1994.tb00321.x"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.12.10.905"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01245973"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.03-0770fje","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.03-0770fje","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.03-0770fje","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:39:50Z","timestamp":1761669590000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.03-0770fje"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1096\/fj.03-0770fje"],"URL":"https:\/\/doi.org\/10.1096\/fj.03-0770fje","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"2003-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}